Mode
Text Size
Log in / Sign up

Surveillance defines acute flaccid myelitis in children during EV-D68 outbreakU.S. surveillance report defines acute flaccid myelitis in children after virus outbreak

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize AFM as a distinct entity defined during the 2014 EV-D68 outbreak.

This surveillance report from the United States in 2014 defined acute flaccid myelitis (AFM) as a distinct clinical entity. The report focused on children across the country who presented with acute limb weakness. The definition emerged following observations made during an outbreak of severe respiratory disease caused by enterovirus D-68 (EV-D68).

No specific intervention, comparator, or primary outcome was reported in this surveillance data. The main finding was the clinical description and temporal association of AFM cases with the EV-D68 outbreak. Exact numbers for sample size, effect measures, and statistical significance were not provided.

Safety and tolerability data, including adverse events, were not reported. The report does not detail specific study limitations, but its nature as surveillance data means it is descriptive and observational. Funding sources and potential conflicts of interest were also not reported.

The practice relevance is that this report established a clinical case definition for AFM in the context of a viral outbreak. It serves as foundational epidemiology, alerting clinicians to a syndrome of acute limb weakness in children. The data highlight an association but do not establish a causal mechanism between EV-D68 and AFM.

This is a public health surveillance report from the United States. It describes how doctors and health officials first recognized acute flaccid myelitis (AFM) as a distinct condition in 2014. This happened after they saw reports of previously healthy children suddenly developing arm or leg weakness. These cases occurred during a large nationwide outbreak of severe respiratory illness caused by a virus called enterovirus D-68 (EV-D68).

The report focused on children across the U.S. It did not involve a specific treatment or intervention. Instead, it was a process of tracking and defining a new pattern of illness. The main finding was that AFM was formally defined as a medical entity following these reports during the EV-D68 outbreak.

It is very important to understand what this report does and does not show. It documents that cases of AFM were reported at the same time as a virus outbreak. This is an association in time, not proof of cause. The report itself does not provide data on how many children were affected, their long-term outcomes, or any specific safety concerns.

Readers should take from this that public health systems work to identify and track new health concerns. This 2014 report was a crucial first step in recognizing AFM. It helped alert doctors and researchers to study this condition further, but much more research was and is needed to understand its causes and find treatments.

What this means for you:
A 2014 report defined AFM in children during a virus outbreak, establishing it for further study but not proving cause.

Study Details

EvidenceLevel 5
PublishedJul 2019
View Original Abstract ↓
Acute flaccid myelitis (AFM) was initially defined as a distinct entity in 2014 following reports of the occurrence of acute limb weakness in previously healthy children across the United States during an outbreak of severe respiratory disease caused by enterovirus D-68 (EV-D68).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.